BRPI1015472A2 - métodos para prevenção e/ou tratamento de doenças degenerativas do sistema nervoso central - Google Patents
métodos para prevenção e/ou tratamento de doenças degenerativas do sistema nervoso centralInfo
- Publication number
- BRPI1015472A2 BRPI1015472A2 BRPI1015472A BRPI1015472A BRPI1015472A2 BR PI1015472 A2 BRPI1015472 A2 BR PI1015472A2 BR PI1015472 A BRPI1015472 A BR PI1015472A BR PI1015472 A BRPI1015472 A BR PI1015472A BR PI1015472 A2 BRPI1015472 A2 BR PI1015472A2
- Authority
- BR
- Brazil
- Prior art keywords
- prevention
- treatment
- methods
- nervous system
- central nervous
- Prior art date
Links
- 210000003169 central nervous system Anatomy 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16810109P | 2009-04-09 | 2009-04-09 | |
| PCT/US2010/030470 WO2010118282A1 (en) | 2009-04-09 | 2010-04-09 | Methods for preventing and/or treating degenerative disorders of the central nervous system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1015472A2 true BRPI1015472A2 (pt) | 2015-11-24 |
Family
ID=42934882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1015472A BRPI1015472A2 (pt) | 2009-04-09 | 2010-04-09 | métodos para prevenção e/ou tratamento de doenças degenerativas do sistema nervoso central |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8304429B2 (https=) |
| EP (1) | EP2416655B1 (https=) |
| JP (1) | JP5634498B2 (https=) |
| CN (1) | CN102448306B (https=) |
| AU (1) | AU2010233187B2 (https=) |
| BR (1) | BRPI1015472A2 (https=) |
| CA (1) | CA2758187C (https=) |
| ES (1) | ES2505243T3 (https=) |
| IL (1) | IL215584A (https=) |
| NZ (1) | NZ595630A (https=) |
| WO (1) | WO2010118282A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8940766B2 (en) * | 2009-04-09 | 2015-01-27 | Amicus Therapeutics, Inc. | Methods for preventing and/or treating lysosomal storage disorders |
| WO2011049737A1 (en) * | 2009-10-19 | 2011-04-28 | Amicus Therapeutics, Inc. | Novel compositions for preventing and/or treating lysosomal storage disorders |
| SI2490532T1 (sl) | 2009-10-19 | 2017-03-31 | Amicus Therapeutics, Inc. | Novi sestavki za preventivo in/ali zdravljenje degenerativnih motenj centralnega živčnega sistema |
| CA3077910A1 (en) | 2010-11-17 | 2012-05-24 | Ionis Pharmaceuticals, Inc. | Modulation of alpha synuclein expression |
| WO2013070981A2 (en) * | 2011-11-08 | 2013-05-16 | University Of Central Florida Research Foundation, Inc. | Treating er stress related disorders by stabilizing intracellular calcium homeostasis |
| US9155695B2 (en) | 2013-03-14 | 2015-10-13 | Medtronic, Inc. | Injectable ropinirole compositions and methods for making and using same |
| WO2015095963A1 (en) | 2013-12-23 | 2015-07-02 | Alectos Therapeutics Inc. | Glucocerebrosidase modulators and uses thereof |
| GB201512203D0 (en) | 2015-07-13 | 2015-08-19 | Lundbeck & Co As H | Agents,uses and methods |
| US10300155B2 (en) | 2015-12-31 | 2019-05-28 | Washington University | Alpha-synuclein ligands |
| CN110177572A (zh) * | 2016-09-12 | 2019-08-27 | 史蒂文·霍夫曼 | 用于治疗痴呆的组合物 |
| AR110074A1 (es) * | 2016-11-15 | 2019-02-20 | H Lundbeck As | Agentes, usos y métodos para el tratamiento de la sinucleinopatía |
| BR112020013994A2 (pt) | 2018-01-12 | 2020-12-08 | Bristol-Myers Squibb Company | Oligonucleotídeos antissenso que direcionam alfa-sinucleína e seus usos |
| EA202091693A1 (ru) | 2018-01-12 | 2021-04-14 | Бристол-Маерс Сквибб Компани | Антисмысловые олигонуклеотиды, целенаправленно воздействующие на альфа-синуклеин, и их применения |
| CN119606967B (zh) * | 2024-12-13 | 2025-09-05 | 合肥工业大学 | 氯雷他定在制备用于预防和治疗血管钙化药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995024391A1 (en) * | 1994-03-09 | 1995-09-14 | Novo Nordisk A/S | Piperidines and pyrrolidines |
| US20060079533A1 (en) * | 2001-03-23 | 2006-04-13 | Nieman James A | Methods of treating alzheimer's disease |
| US6770625B2 (en) * | 2001-09-07 | 2004-08-03 | Nobex Corporation | Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith |
| US6670625B1 (en) * | 2002-06-18 | 2003-12-30 | Ge Medical Systems Global Technology Company, Llc | Method and apparatus for correcting multipole aberrations of an electron beam in an EBT scanner |
| JP2006507359A (ja) * | 2002-10-28 | 2006-03-02 | ノボ・ノルデイスク・エー／エス | 心循環器疾患の治療のためのグリコーゲンホスホリラーゼ阻害剤の使用 |
| CN101541172A (zh) * | 2005-06-08 | 2009-09-23 | 阿米库斯治疗学公司 | 溶酶体酶编码基因突变相关的cns紊乱的治疗 |
| JP5303458B2 (ja) * | 2006-06-23 | 2013-10-02 | アミークス セラピューティックス インコーポレイテッド | β−グルコセレブロシダーゼの活性増強による神経学的疾患の治療方法 |
| US20080009156A1 (en) | 2006-07-10 | 2008-01-10 | Malin Glen K | System and method for bonding coaxial cable |
| US8940766B2 (en) * | 2009-04-09 | 2015-01-27 | Amicus Therapeutics, Inc. | Methods for preventing and/or treating lysosomal storage disorders |
-
2010
- 2010-04-09 CA CA2758187A patent/CA2758187C/en not_active Expired - Fee Related
- 2010-04-09 NZ NZ595630A patent/NZ595630A/xx not_active IP Right Cessation
- 2010-04-09 AU AU2010233187A patent/AU2010233187B2/en not_active Ceased
- 2010-04-09 JP JP2012504880A patent/JP5634498B2/ja active Active
- 2010-04-09 CN CN201080024142.1A patent/CN102448306B/zh not_active Expired - Fee Related
- 2010-04-09 WO PCT/US2010/030470 patent/WO2010118282A1/en not_active Ceased
- 2010-04-09 US US12/757,144 patent/US8304429B2/en not_active Expired - Fee Related
- 2010-04-09 BR BRPI1015472A patent/BRPI1015472A2/pt not_active Application Discontinuation
- 2010-04-09 EP EP10762468.6A patent/EP2416655B1/en active Active
- 2010-04-09 ES ES10762468.6T patent/ES2505243T3/es active Active
-
2011
- 2011-10-06 IL IL215584A patent/IL215584A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL215584A (en) | 2016-11-30 |
| ES2505243T3 (es) | 2014-10-09 |
| US20100261753A1 (en) | 2010-10-14 |
| CN102448306B (zh) | 2014-07-02 |
| AU2010233187B2 (en) | 2015-10-08 |
| JP5634498B2 (ja) | 2014-12-03 |
| EP2416655B1 (en) | 2014-06-25 |
| CA2758187C (en) | 2017-03-07 |
| US8304429B2 (en) | 2012-11-06 |
| EP2416655A1 (en) | 2012-02-15 |
| CN102448306A (zh) | 2012-05-09 |
| HK1168005A1 (zh) | 2012-12-21 |
| CA2758187A1 (en) | 2010-10-14 |
| WO2010118282A1 (en) | 2010-10-14 |
| AU2010233187A1 (en) | 2011-11-03 |
| EP2416655A4 (en) | 2012-09-05 |
| IL215584A0 (en) | 2011-12-29 |
| JP2012523430A (ja) | 2012-10-04 |
| NZ595630A (en) | 2013-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1015472A2 (pt) | métodos para prevenção e/ou tratamento de doenças degenerativas do sistema nervoso central | |
| PT2470191E (pt) | Métodos e composições para prevenção ou tratamento de doenças oftálmicas | |
| BR112012007950A2 (pt) | método para tratar água residual e sistema de tratamento | |
| BRPI1013705A2 (pt) | compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica | |
| BRPI0717482A2 (pt) | Sistema para o tratamento de uma alimentação de hidrocarboneto | |
| BRPI1015569A2 (pt) | compostos úteis para o tratamento de doenças degenerativas e inflamatórias. | |
| HUE046610T2 (hu) | Probiotikus készítmény kutyák gyomor-bélrendszeri rendellenességeinek megelõzésére vagy kezelésére | |
| BRPI0807987A2 (pt) | Terapia de combinação para tratamento de distúrbios imunes. | |
| BR112012000422A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para a prevenir tratar ou melhorar doenças do sistema imune | |
| BR112013016535A2 (pt) | extratos vegetais para o tratamento e prevenção de infecções | |
| BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
| HUE049880T2 (hu) | Anyag és eljárások Her-3-mal összefüggõ betegségek kezelésére vagy megelõzésére | |
| BRPI1008909A2 (pt) | métodos e sistema de tratamento de veia | |
| BRPI1013559A2 (pt) | compostos, composição farmacêutica, método de tratamento de doença ou condição associada à função trpa1 e respectivos usos | |
| BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
| BRPI1014864A2 (pt) | "implante de processos espinhosos e métodos associados" | |
| BR112014002619A2 (pt) | composição farmacêutica e método de tratamento e/ou prevenção de câncer pancreático e combinação farmacêutica | |
| BR112013015870A2 (pt) | método para o tratamento de biomassa e sistema | |
| BR112013021984A2 (pt) | métodos e sistema de tratamento de poço | |
| BR112012002265A2 (pt) | composições farmacêuticas para o tratamento de câncer e outras doenças ou distúrbios | |
| BRPI0909628A2 (pt) | compostos de azaindol para o tratamento de distúrbios do sistema nervosos central | |
| BR112013024169A2 (pt) | método para o tratamento e prevenção da doença de parkinson | |
| BR112012033536A2 (pt) | sistema de esterilização através de chuveiro e método de utilização | |
| BR112013013898A2 (pt) | compostos de pirimidinona para o uso no tratamento de doenças ou condições mediadas por lp-pla2 | |
| BRPI1010517A2 (pt) | métodos para prevenção e/ou tratamento de doenças de armazenamento lisossomal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |